Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01] Clinical Trials

143 clinical trials for Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01] across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Phase 2 diagnostic study with 68Ga-EVG321 in Patients with Small Cell Lung Cancer — RECRUITING · PHASE2
• Prospective, Multi-Center Study to Assess the Diagnostic Performance of [18F]PSMA-1007 PET/CT Imaging in Patients with Newly-Diagnosed High-Risk or Very-High-Risk Prostate Cancer — RECRUITING · PHASE3
• A Phase 2/3, Multicenter, Open-Label, Non-Randomized Study to Evaluate Diagnostic Performance of GEH300079 (68Ga) Injection Positron-Emission Tomography (PET)/Computed Tomography (CT) for Detection of Peritoneal Carcinomatosis (PC) in Patients with Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE) — RECRUITING · PHASE3
• LIBERATE; From Inflammation Biomarkers to Remodelling (FAPI PET/CT) towards personalized diagnosis in post-acute sequelae of COVID-19 — RECRUITING · PHASE3
• Measuring of the duration of action of different doses of rocuronium-induced neuromuscular block in infants during surgical treatment of craniosynostosis - a prospective, case-controlled study — RECRUITING · PHASE4
• [⁶⁸Ga]Ga-HKG301 PET/CT for staging and restaging patients with primary breast cancer: a phase II study (FAPILOUS) — NOT_YET_RECRUITING · PHASE2
• International, multicenter, blinded phase III clinical trial to assess the diagnostic efficacy of the skin prick test from ROXALL (SPT-RX) with different allergen extract solutions for in vivo diagnosis of IgE mediated allergies — NOT_YET_RECRUITING · PHASE3
• An Open-label, Single-dose, Safety and Pharmacokinetic Study of Regadenoson in Paediatric Patients — TERMINATED · PHASE2
• PET/CT imaging with FAPI to predict response to anti-inflammatory therapy in patients with fibrotic interstitial lung disease: “The FIBRO-PET Study” — TERMINATED · PHASE2
• First-in-human (FIH), microdosing, non-randomized, clinical trial to investigate binding of positron emission tomography tracer [68Ga]Ga-DOTA-Cys-ATH001 targeting platelet derived growth factor receptor β in healthy subjects as compared to patients with metabolic dysfunction-associated steatohepatitis (MASH) and Primary Sclerosing Cholangitis binding (PSC, liver) and patients with fibrostenotic Crohn’s disease (CD, gastrointestinal tract [GI]) — TERMINATED · PHASE1
• VATS or Intrapleural Enzymatic Therapy for patientS with empyema (the VIETS trial) — NOT_YET_RECRUITING · PHASE4
• MECHANISMS OF NEURONAL RESILIENCE IN ALZHEIMER'S DISEASE AND ITS FOCAL VARIANTS: A MRI/PET STUDY — NOT_YET_RECRUITING · PHASE3
• 161Tb-labeled Gastrin Analogue - A Novel Tool for Precision Treatment of Advanced Medullary Thyroid Cancer — OTHER · PHASE1
• CAT-VHL - Exploring the role of Carbonic Anhydrase IX as diagnostic and Theranostic target in Von-Hippel Lindau disease — NOT_YET_RECRUITING · PHASE2
• A pilot study of the safety and tolerability of oral administration of PD L 506 and the subsequent diagnostic value of porphyrin concentration (coproporphyrin I / III, CP I / III) in urine in patients with the first occurrence of colorectal cancer and in healthy subjects. — TERMINATED · PHASE2
• MYELOFLUDATEP: Exploratory study evaluating the value of 18F-Fludarabine PET for the initial or relapsed assessment and therapeutic evaluation of patients with symptomatic multiple myeloma. — TERMINATED · PHASE1
• In vivo biological standardization of Olea europaea allergen extracts. — TERMINATED · PHASE2
• An open non-randomized phase IV trial examining interfering cross-reactivity in serological diagnostics of flavivirus infections in Swedish travelers following vaccination with the live dengue vaccine Qdenga — TERMINATED · PHASE4
• Hippocrates; The use of FAPI-PET/CT and FDG-PET/CT scan in acute and chronic phase Peyronie’s disease for detection of active fibroblasts and inflammation in the penis - a pilot study — TERMINATED · PHASE4
• 18F-fluoro-ethyl-tyrosine (18FET) PET for difficult clinical situations in functional pituitary adenoma. A prospective, single arm, single center study. (FET-PIT) — NOT_YET_RECRUITING · PHASE2
• LAFOV-Lung PET — NOT_YET_RECRUITING · PHASE1
• Exploratory study evaluating the relevance of [68Ga]Ga-PentixaFor for initial staging and therapeutic evaluation of symptomatic multiple myeloma patients in first line treatment or in relapse. — TERMINATED · PHASE2
• ECETEP : Pilot study evaluating PSMA positron emission tomography for monitoring clinically significant prostate cancer after focal HIFU treatment — NOT_YET_RECRUITING · PHASE4
• Prospective head-to-head comparison of cardiac [18F]-MFBG PET versus [123I]-MIBG SPECT in the differentiation between Parkinson’s disease and multiple system atrophy and between dementia with Lewy bodies and Alzheimer’s disease. — TERMINATED · PHASE3
• BIOLOGICAL STANDARDISATION OF ALLERGENIC EXTRACTS OF MITES (Dermatophagoides pteronyssinus, Dermatophagoides farinae, Blomia tropicalis and Lepidoglyphus destructor) TO DETERMINE BIOLOGICAL ACTIVITY IN HISTAMINE EQUIVALENT UNITS (HEP) IN SENSITIVISED PATIENTS. — OTHER · PHASE2
• Ventricular water absorption capacity in hydrocephalus — TERMINATED · PHASE3
• Accuracy for Imaging Cardiac Sarcoidosis with 68Ga-Pentixafor Positron Emission Tomography/Computed Tomography (68Ga-Pentixafor PET/CT): ASPECT study — NOT_YET_RECRUITING · PHASE2
• VASCULAR AND RENAL IMPACT OF ENDOTHELIN-1 RECEPTOR BLOCKADE IN PATIENTS WITH UNCONTROLLED ARTERIAL HYPERTENSION - ENDOTHELIN-2 — OTHER · PHASE2
• Exploratory study evaluating the relevance of [68Ga]Ga-FAPI-46 for staging and identifying progressing patients with transthyretin cardiac amyloidosis — NOT_YET_RECRUITING · PHASE2
• An open-label, two-part, phase 2 clinical trial to investigate the safety and diagnostic performance of uPAR PET imaging for non-invasive classification of ISUP grades among patients with localised, untreated prostate cancer. — TERMINATED · PHASE2
• Biodistribution Evaluation to Reduce Administered Radiopharmaceutical Dose on LOng Axial Field of VieW PET Scanners – BELOW trial — TERMINATED · PHASE1
• A first-in-human study to determine the safety and tolerability of different doses of GEH200520 Injection and GEH200521 (18F) Injection and their uses in positron emission tomography imaging for patients with cancer — OTHER · PHASE1
• 18F-FDG versus 68Ga-FAPI-46 as PET tracer in ER-positive breast cancer - a pilot study — TERMINATED · PHASE2
• T cell imaging in kidney transplantation (TIK) — NOT_YET_RECRUITING · PHASE1
• Chronic kidney disease – imaging the metabolic derangements with ultra-sensitive MRI — TERMINATED · PHASE2
• Prognostic Performance of Quantitative Myocardial Perfusion Imaging Using H2[15O] Positron Emission Tomography in Coronary Artery Disease - The AQUA COR trial — NOT_YET_RECRUITING · PHASE3
• Intrapatient comparison of 68Ga-gozetotide (PSMA) PET and 89Zr-girentuximab PET in clear cell renal cell carcinoma (ISEE-RCC) — TERMINATED · PHASE3
• BEFAST STUDY: [68Ga]Ga-FAPI total body PET/CT for Better and Faster imaging in cancer [68Ga]Ga-FAPI PET/CT for response evaluation during immune checkpoint inhibitor therapy in malignant melanoma — TERMINATED · PHASE2
• Clinical performance study of a new diagnostic test for drug sensitivity evaluation in metastatic colorectal cancer — TERMINATED · PHASE2
• An open-label, single-center study to evaluate the safety and test-retest characteristics of [11C]MODAG-005 as PET radioligand for imaging pathological alpha-synuclein deposition in the brains of patients with Parkinson’s disease (PD) or Multiple System Atrophy (MSA) compared to age-matched healthy controls (AMHC) — TERMINATED · PHASE1
• 68Ga-FAPI PET/CT imaging to assess pulmonary artery and right ventricle remodeling SoFAPI study — NOT_YET_RECRUITING · PHASE3
• Functional lung avoidance planning guided by lung perfusion PET/CT versus anatomical planning for lung stereotactic body radiotherapy: a double blinded, randomized, controlled trial — NOT_YET_RECRUITING · PHASE3
• "Contribution of 68Ga-FAPI-46 PET-CT in the initial staging of gastric cancers eligible for curative treatment" "FAPGASTRO" — NOT_YET_RECRUITING · PHASE2
• Evaluating the Diagnostic Performance of Human Epidermal Growth Factor Receptor 2 (HER2) targeted Positron Emission Tomography and Computed Tomography (PET/CT) with 68Ga-ABS011 in metastatic Breast Cancer (mBC) and other metastatic solid carcinomas. — TERMINATED · PHASE3
• Prospective evaluation of potential effects of repeated gadolinium-based contrast agent (GBCA) administrations of the same GBCA on motor and cognitive functions in neurologically normal adults in comparison to a non-GBCA exposed control group—ODYSSEY — NOT_YET_RECRUITING · PHASE4
• FAPI PET in Pleural Mesothelioma: The Diagnostic Accuracy and Clinical Value of FAPI PET at Diagnosis, Primary Staging, and the Feasibility of FAPI PET for Response Evaluation — TERMINATED · PHASE2
• In vivo biological standardization of Dermatophagoides allergen extracts. — TERMINATED · PHASE2
• Longitudinal study with positron emission tomography using [18F]PI-2620 in primary tauopathies. Proof-of-concept study — TERMINATED · PHASE2
• iMagIng pulmonaRy Aspergillosis using Gallium-68-dEferoxamine (MIRAGE) — OTHER · PHASE2
• PET imaging of tumors with strong desmoplastic reaction in pancreas, bile ducts, ventricle and ovaries by a novel tracer, 68Ga-FAPI-46 = Fibroblast Activation Protein Inhibitor — TERMINATED · PHASE2

Refine this search